Press Releases Dangerously Overprescribed Gabapentin Should be Classified as a Controlled Substance February 9, 2022
Press Releases Public Citizen Statement: CMS Follows the Science, Makes the Right Call in Proposing Medicare Coverage for the Alzheimer’s Disease Drug Aducanumab Only for Beneficiaries Who Enroll in a Randomized Clinical Trial January 11, 2022
Press Releases Report: Johnson & Johnson Fails to Deliver Any Contracted Doses to COVAX in October, While Providing 12 Million to Wealthy Countries November 23, 2021
Press Releases Statement: WHO License Is a Model for Sharing Medical Technology With Humanity November 23, 2021
Press Releases Statement: White House Plan To Ramp Up Vaccine Production at Last Can Save Lives; Yet More is Needed November 17, 2021
Press Releases Nearly 90 Organizations Demand Moderna CEO Work with WHO To Supply Vaccines To Low-Income Nations November 16, 2021
Press Releases Statement: FDA’s Reckless Decision to Approve Ineffective Alzheimer’s Disease Drug Causing Financial Pain for All Medicare Part B Beneficiaries November 15, 2021
Press Releases Statement: In Vaccine Patent Fight, NIH Shows a Modicum of Verve at Last November 10, 2021
Press Releases Statement: Democrats’ Drug Pricing Agreement: A Step Forward, Although Americans Deserve More November 2, 2021